SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Yang Patrick Y – ‘4’ for 3/26/09 re: Genentech Inc.

On:  Monday, 4/20/09, at 6:07pm ET   ·   For:  3/26/09   ·   As:  Officer   ·   Accession #:  1181431-9-20425   ·   File #:  1-09813

Previous ‘4’:  ‘4’ on 7/23/08 for 7/21/08   ·   Next:  ‘4’ on 1/3/11 for 12/31/10   ·   Latest:  ‘4’ on 3/11/24 for 3/8/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/20/09  Yang Patrick Y                    4          Officer     1:21K  Genentech Inc.                    R R Donnelley … Filer/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Roche Buyout - Py -- rrd240193.xml/3.3              HTML     20K 




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Roche Buyout – Py
 
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Yang Patrick Y

(Last)(First)(Middle)
1 DNA WAY

(Street)
SOUTH SAN FRANCISCOCA94080

(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
GENENTECH INC [ DNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
XOfficer (give title below) Other (specify below)
EVP, Product Operations
3. Date of Earliest Transaction (Month/Day/Year)
3/26/09
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock 3/26/09 GV274D$02,040D
Common Stock 3/26/09 GV294D$01,746D
Common Stock 3/26/09 D 1,746D$95 (1)0D
Common Stock 3/26/09 D 1,866D$95 (1)0Iby Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (Right to Buy)$43.36 3/26/09 D 15,000 (2) 12/3/03 (2) 12/3/13Common Stock15,000$0 (2)0D
Non-Qualified Stock Option (Right to Buy)$53.23 3/26/09 D 60,000 (2) 9/23/04 (2) 9/23/14Common Stock60,000$0 (2)0D
Non-Qualified Stock Option (Right to Buy)$79.17 3/26/09 D 135,000 (2) 9/20/07 (2) 9/20/16Common Stock135,000$0 (2)0D
Non-Qualified Stock Option (Right to Buy)$79.55 3/26/09 D 125,000 (2) 9/20/08 (2) 9/20/17Common Stock125,000$0 (2)0D
Non-Qualified Stock Option (Right to Buy)$85.83 3/26/09 D 125,000 (2) 9/23/05 (2) 9/23/15Common Stock125,000$0 (2)0D
Non-Qualified Stock Option (Right to Buy)$48.3 3/26/09 D 1,200 (2) 1/23/04 (2) 1/23/14Common Stock1,200$0 (2)0Iby Spouse
Non-Qualified Stock Option (Right to Buy)$53.23 3/26/09 D 850 (2) 9/23/04 (2) 9/23/14Common Stock850$0 (2)0Iby Spouse
Non-Qualified Stock Option (Right to Buy)$79.17 3/26/09 D 1,120 (2) 9/20/07 (2) 9/20/16Common Stock1,120$0 (2)0Iby Spouse
Non-Qualified Stock Option (Right to Buy)$79.55 3/26/09 D 1,700 (2) 9/20/08 (2) 9/20/17Common Stock1,700$0 (2)0Iby Spouse
Non-Qualified Stock Option (Right to Buy)$85.83 3/26/09 D 1,500 (2) 9/23/05 (2) 9/23/15Common Stock1,500$0 (2)0Iby Spouse
Explanation of Responses:
(1)  Disposed of pursuant to the Agreement and Plan of Merger between the issuer, Roche Holdings Inc. and Roche Investments USA dated March 12, 2009
(2)  At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.
/s/ Adam B. Lautner, Power of Attorney 4/20/09
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
____________
Transaction Codes:
    D    Disposition to the Issuer of Issuer equity securities pursuant to Rule 16b-3(e).
    G    Bona fide gift.

Top
Filing Submission 0001181431-09-020425   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 6:18:28.1am ET